| Janssen-Cilag AG - Rybrevant SC 1600 mg/10 ml, Injektionslösung | | 69839 | | 01 | | Rybrevant SC 1600 mg/10 ml | | Injektionslösung | | L01FX18 | | Amivantamab | | 28.01.2026 | | |
| | Composition | | amivantamabum 1600 mg, hyaluronidasum humanum ADNr, natrii acetas trihydricus, acidum aceticum glaciale, saccharum, polysorbatum 80 6 mg, methioninum, dinatrii edetas, aqua ad iniectabile q.s. ad solutionem pro 10 ml corresp. natrium 6.19 mg. | | Packungsbestandteile | | Injection solution | | | | | | | | Active Agent | Dose |
|---|
| Amivantamabum | 1600mg / 10ml |
| | BAG: Active Agent | Dose |
|---|
| Amivantamabum | 1600 mg |
| | | | Inactive agents | Dose |
|---|
| Acidum Aceticum Glaciale | | | Dinatrii Edetas | | | Hyaluronidasum Humanum Adnr | | | Methionine | | | Natrii Acetas Trihydricus | | | Polysorbatum 80 | 6mg / 10ml | | Saccharum | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | 3538.02 | 3864.25 | A | SL | No |
|
|
